Aptargroup (ATR) Cash & Equivalents (2009 - 2026)
Aptargroup's (ATR) quarterly Cash & Equivalents came in at $222.5 million in Q1 2026, up 76.84% year-on-year from $125.8 million in Q1 2025, and down 44.7% on a QoQ basis from $402.4 million in Q4 2025.
Aptargroup (ATR) Cash & Equivalents (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Cash & Equivalents data on file, last reported at $222.5 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 76.84% year-over-year to $222.5 million in Q1 2026; TTM through Mar 2026 was $222.5 million, a 76.84% increase from a year earlier, with the FY2025 full-year figure at $402.4 million, up 79.78% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $222.5 million, down from $402.4 million in the prior quarter.
- Over the last five years, Cash & Equivalents for ATR reached as high as $402.4 million in Q4 2025 and fell as low as $121.0 million in Q2 2023.
- Historically, Cash & Equivalents has averaged $213.3 million across 5 years, with a median of $221.5 million in 2024.
- Across the five-year window, Cash & Equivalents plunged 64.34% in 2023 and soared 114.76% in 2024, its largest moves.
- Year by year, Cash & Equivalents stood at $141.7 million in 2022, then surged by 57.79% to $223.6 million in 2023, then advanced by 0.09% to $223.8 million in 2024, then jumped by 79.78% to $402.4 million in 2025, then plunged by 44.7% to $222.5 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $222.5 million in Q1 2026, $402.4 million in Q4 2025, and $257.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Aptargroup | 9.43 Bn | 9.23 Bn | 351.91 Mn | 222.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222.53 Mn |
| Dec 31, 2025 | 402.42 Mn |
| Sep 30, 2025 | 257.06 Mn |
| Jun 30, 2025 | 161.73 Mn |
| Mar 31, 2025 | 125.84 Mn |
| Dec 31, 2024 | 223.84 Mn |
| Sep 30, 2024 | 325.52 Mn |
| Jun 30, 2024 | 221.49 Mn |
| Mar 31, 2024 | 199.83 Mn |
| Dec 31, 2023 | 223.64 Mn |
| Sep 30, 2023 | 151.57 Mn |
| Jun 30, 2023 | 120.98 Mn |
| Mar 31, 2023 | 126.81 Mn |
| Dec 31, 2022 | 141.73 Mn |
| Sep 30, 2022 | 124.81 Mn |
| Jun 30, 2022 | 240.47 Mn |
| Mar 31, 2022 | 355.63 Mn |
| Dec 31, 2021 | 122.93 Mn |
| Sep 30, 2021 | 114.56 Mn |
| Jun 30, 2021 | 291.50 Mn |